Flora Growth Financials
FLGC Stock | USD 0.77 0.02 2.53% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 1.43 | 1.51 |
|
|
The financial analysis of Flora Growth is a critical element in measuring its lifeblood. Investors should not minimize Flora Growth's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Flora | Select Account or Indicator |
Understanding current and past Flora Growth Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Flora Growth's financial statements are interrelated, with each one affecting the others. For example, an increase in Flora Growth's assets may result in an increase in income on the income statement.
Please note, the presentation of Flora Growth's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Flora Growth's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Flora Growth's management manipulating its earnings.
Flora Growth Stock Summary
Flora Growth competes with Painreform, INC Research, Petros Pharmaceuticals, Sunshine Biopharma, and Sonoma Pharmaceuticals. Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies worldwide. Flora Growth Corp. was incorporated in 2019 and is headquartered in Toronto, Canada. FLORA GROWTH operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 277 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | CA3397641026 |
CUSIP | 339764102 339764201 |
Location | Florida; U.S.A |
Business Address | 3406 SW 26th |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.floragrowth.com |
Phone | 954 842 4989 |
Currency | USD - US Dollar |
Flora Growth Key Financial Ratios
Return On Equity | -1.35 | ||||
Profit Margin | (0.22) % | ||||
Operating Margin | (0.20) % | ||||
Price To Sales | 0.19 X | ||||
Revenue | 76.07 M |
Flora Growth Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 19.5M | 85.5M | 81.0M | 23.6M | 27.2M | 46.4M | |
Other Current Liab | 1.2M | 2.9M | 7.4M | 8.4M | 9.7M | 10.2M | |
Net Debt | (14.9M) | (36.3M) | (5.4M) | (678K) | (779.7K) | (818.7K) | |
Retained Earnings | (17.3M) | (38.5M) | (90.9M) | (142.5M) | (128.3M) | (121.9M) | |
Accounts Payable | 1.2M | 2.4M | 7.8M | 5.1M | 5.9M | 3.7M | |
Cash | 15.5M | 37.6M | 9.5M | 4.4M | 5.0M | 4.8M | |
Net Receivables | 1.2M | 5.6M | 9.0M | 7.1M | 8.2M | 5.1M | |
Other Current Assets | 347K | 1.7M | 7.1M | 1.4M | 1.6M | 2.4M | |
Total Liab | 3.2M | 8.5M | 24.6M | 17.2M | 19.8M | 12.3M | |
Net Invested Capital | 16.7M | 77.2M | 57.9M | 8.3M | 9.6M | 9.1M | |
Short Long Term Debt | 251K | 18K | 1.1M | 1.9M | 2.2M | 2.3M | |
Total Current Assets | 17.6M | 47.9M | 31.2M | 21.4M | 24.6M | 26.1M | |
Net Working Capital | 14.9M | 41.8M | 13.7M | 5.1M | 5.8M | 5.6M | |
Short Term Debt | 329K | 842K | 2.2M | 2.7M | 3.1M | 1.6M | |
Intangible Assets | 658K | 9.7M | 18.1M | 946K | 1.1M | 1.0M |
Flora Growth Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Interest Expense | 30K | 84K | 56K | 92K | 105.8K | 61.9K | |
Gross Profit | 71K | 2.4M | 14.4M | 17.7M | 20.4M | 21.4M | |
Operating Income | (12.3M) | (19.0M) | 3.3M | (50.4M) | (45.3M) | (43.1M) | |
Ebit | (14.3M) | (19.0M) | (20.1M) | (48.2M) | (43.4M) | (41.2M) | |
Research Development | 78K | 132K | 430K | 62K | 71.3K | 67.7K | |
Ebitda | (14.2M) | (18.2M) | (17.9M) | (45.9M) | (41.3M) | (39.2M) | |
Cost Of Revenue | 35K | 6.6M | 22.8M | 58.3M | 67.1M | 70.4M | |
Income Before Tax | (14.3M) | (21.5M) | (54.2M) | (48.3M) | (43.5M) | (45.6M) | |
Net Income | (14.3M) | (21.4M) | (52.6M) | (57.0M) | (51.3M) | (48.8M) | |
Income Tax Expense | (75K) | (98K) | (1.5M) | (1.6M) | (1.5M) | (1.4M) | |
Minority Interest | (113K) | 112K | 214K | 489K | 562.4K | 590.5K |
Flora Growth Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Change In Cash | 15.4M | 22.1M | (28.1M) | (4.6M) | (4.1M) | (3.9M) | |
Free Cash Flow | (8.7M) | (24.6M) | (17.2M) | (8.6M) | (7.7M) | (8.1M) | |
Depreciation | 113K | 765K | 2.6M | 2.5M | 2.9M | 3.0M | |
Other Non Cash Items | 30K | 3.7M | 28.4M | 37.2M | 42.7M | 44.9M | |
Capital Expenditures | 234K | 4.0M | 1.3M | 163K | 187.5K | 178.1K | |
Net Income | (14.3M) | (21.4M) | (52.6M) | (47.4M) | (42.6M) | (44.8M) | |
End Period Cash Flow | 15.5M | 37.6M | 9.5M | 4.4M | 5.0M | 4.8M |
Flora Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Flora Growth's current stock value. Our valuation model uses many indicators to compare Flora Growth value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Flora Growth competition to find correlations between indicators driving Flora Growth's intrinsic value. More Info.Flora Growth Corp is rated below average in return on equity category among its peers. It is rated # 5 in return on asset category among its peers . At present, Flora Growth's Return On Equity is projected to drop based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Flora Growth's earnings, one of the primary drivers of an investment's value.Flora Growth Corp Systematic Risk
Flora Growth's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Flora Growth volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-five with a total number of output elements of sixteen. The Beta measures systematic risk based on how returns on Flora Growth Corp correlated with the market. If Beta is less than 0 Flora Growth generally moves in the opposite direction as compared to the market. If Flora Growth Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Flora Growth Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Flora Growth is generally in the same direction as the market. If Beta > 1 Flora Growth moves generally in the same direction as, but more than the movement of the benchmark.
Flora Growth Thematic Clasifications
Flora Growth Corp is part of several thematic ideas from Drugs to Health Management. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasToday, most investors in Flora Growth Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Flora Growth's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Flora Growth growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Flora Growth January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Flora Growth help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Flora Growth Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Flora Growth Corp based on widely used predictive technical indicators. In general, we focus on analyzing Flora Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Flora Growth's daily price indicators and compare them against related drivers.
Information Ratio | (0.13) | |||
Maximum Drawdown | 50.27 | |||
Value At Risk | (12.63) | |||
Potential Upside | 10.83 |
Complementary Tools for Flora Stock analysis
When running Flora Growth's price analysis, check to measure Flora Growth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Flora Growth is operating at the current time. Most of Flora Growth's value examination focuses on studying past and present price action to predict the probability of Flora Growth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Flora Growth's price. Additionally, you may evaluate how the addition of Flora Growth to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |